“We are delighted that AstraZeneca is joining as a Vivli member and making it possible for researchers to access the data from their clinical trials,” said Rebecca Li, Vivli Executive Director.

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

“AstraZeneca is very pleased to be joining Vivli,” said Julie Holtzople at AstraZeneca. “Through Vivli, we will strengthen our external data sharing capabilities with best-in-class research tools and the Wellcome Trust Independent Review Panel (IRP) in service of advancing human health.”